Slow or Fast Caffeine Metaboliser: Why Coffee Affects Everyone Differently

You almost certainly know someone who knocks back a double espresso after dinner and sleeps like a baby. Meanwhile, a single coffee at mid-afternoon is enough to keep you wide awake until midnight. It's not in your head, and it's not a matter of willpower — it's largely a question of genetics. At the heart of this difference lies a gene with a dry name but very real effects: CYP1A2.

The enzyme that handles almost all your caffeine

CYP1A2 is an enzyme produced by the liver, responsible for breaking down around 95% of the caffeine you consume. This enzyme belongs to the large cytochrome P450 family, which plays a central role in eliminating drugs, toxins, and many active substances. What makes CYP1A2 particularly interesting is that its activity level varies considerably from person to person — and this variability is largely hereditary.

Within the CYP1A2 gene, a specific genetic variant called rs762551 (also written as CYP1A2*1F) has been linked to the duration and intensity of caffeine's effects. This variant is a simple single-letter substitution in the DNA sequence — an "A" or a "C" — that is enough to change the pace at which your liver processes your morning cup.

Fast, intermediate, or slow: three very different profiles

You inherit two copies of the CYP1A2 gene — one from each parent. Depending on the combination of alleles you carry, you fall into one of the following profiles:

How quickly does your liver work?

The half-life of caffeine — the time it takes your body to eliminate half of it — varies considerably between individuals, generally between 3 and 7 hours in healthy adults. In fast metabolisers, some estimates place this half-life towards the lower end of this range (2 to 4 hours), whilst in slow metabolisers it can reach 5 to 9 hours or more. This means that, in practical terms, for two people who drank the same coffee at 3pm, one may have eliminated almost all the caffeine by bedtime, whilst the other still carries a significant dose.

To visualise this in your daily life, PauseCafé's active caffeine curve shows you in real time how much caffeine is still circulating in your body, hour by hour — a particularly revealing tool if you suspect you might be a slow metaboliser.

What the science says: the study that changed everything

It was in 2006 that a study published in the Journal of the American Medical Association (JAMA) truly brought the CYP1A2 genotype question to the forefront of scientific debate. Cornelis, El-Sohemy, Kabagambe, and Campos analysed data from 2,014 people who had experienced a first non-fatal myocardial infarction, compared with 2,014 controls, determining the CYP1A2 genotype and habitual coffee consumption for each participant. Their conclusion made a lasting impression: high coffee consumption was associated with an increased risk of non-fatal myocardial infarction only in slow metabolisers, suggesting a direct role for caffeine in this association.

It is important to note the study's limitations: it focused on a Central American population (Costa Rica), and the results are not necessarily generalisable to all populations. Furthermore, it was a case-control study, which establishes an association rather than direct causation. Other work carried out since has added nuance to this picture, with some studies failing to replicate the same results in other cohorts — science rarely advances in a straight line.

Sports performance: the gene that divides athletes

The debate around CYP1A2 is not limited to cardiovascular risk. More recent research has explored its influence on the caffeine response in a sporting context. Studies suggest that fast metabolisers (AA genotype) generally derive a greater ergogenic benefit from caffeine — improved endurance, increased alertness, reduced perception of effort — than metabolisers carrying the C allele. Conversely, slow metabolisers more frequently experience adverse effects at equivalent doses: increased heart rate, anxiety, and digestive discomfort.

This helps explain in part why the relationship between caffeine and sports performance is so variable from one individual to another: two athletes following exactly the same supplementation protocol can have radically different experiences. Genotype is one piece of this puzzle.

Factors that modulate CYP1A2 activity beyond your genes

Your genotype provides a tendency, not a fixed destiny. Several environmental and physiological factors modulate the actual activity of the enzyme:

• Smoking: cigarette smoke is a powerful inducer of CYP1A2; smokers metabolise caffeine significantly faster than non-smokers, regardless of their baseline genotype.
• Pregnancy: CYP1A2 activity decreases significantly during pregnancy, slowing caffeine metabolism — which partly explains the reinforced precautionary recommendations for pregnant women (WHO/ANSES threshold of around 200 mg/day).
• Certain medications: common drugs (certain antibiotics, antiulcer agents, antidepressants) inhibit or induce CYP1A2, altering the duration of caffeine's action. This is another reason to discuss this with a doctor or pharmacist if you are on regular medication.
• Diet: cruciferous vegetables (broccoli, Brussels sprouts) moderately stimulate enzyme activity; grapefruit juice, by contrast, can inhibit it.
• Habitual coffee consumption: regular, high consumption can induce the enzyme in AA genotypes, further accelerating metabolism. Tolerance is therefore not only neurological — it is also enzymatic.

What can you do with this information?

Knowing your metabolic profile can help you better understand your own reactions to caffeine, but a few caveats are necessary:

1. Your own experience is the most accessible indicator. Trouble sleeping after a late-afternoon coffee? Palpitations, nervousness, headaches? These signals are valuable, whatever your genetics. The article on caffeine and sleep from personal data explains how to identify these effects.
2. Consumer genetic tests exist, but with limitations. Services like 23andMe or specialised tests can tell you your rs762551 genotype. However, interpretation remains complex: genotype is one factor among many, and results do not constitute medical advice in any way.
3. Official thresholds remain valid reference points for everyone. EFSA and the FDA place the safety limit for a healthy adult at 400 mg of caffeine per day. This value is defined for the general population and does not account for genotype — slow metabolisers may experience adverse effects well below this threshold.
4. The timing of your last coffee matters for everyone, but even more so for slow metabolisers. If you suspect a slow metabolism, moving your last coffee from 3pm to 1pm can make a real difference to your sleep quality.

Tracking your caffeine intake precisely — and cross-referencing it with your nights — is a simple and effective approach to start understanding your own profile, without any genetic testing. That is exactly what PauseCafé's correlation analyses make possible, comparing your consumption habits with your sleep data to surface your own personal patterns.

What genetics cannot (yet) do for you

It would be tempting to conclude that fast metabolisers can drink as much coffee as they like, and that slow metabolisers should avoid it altogether. The reality is more nuanced. Individual tolerance depends on dozens of factors — stress levels, sleep quality, health status, drug interactions — that are largely beyond genetics. Large-scale studies on hundreds of thousands of participants have not always found a significant effect of CYP1A2 genotype on the cardiovascular risk associated with coffee, underscoring the complexity of these interactions.

Genetics illuminates — it does not decide. It is one piece of the puzzle — a fascinating one, increasingly accessible — but listening to your own body remains irreplaceable. If you would like to go further in understanding your personal caffeine tolerance, our article on caffeine tolerance explores the mechanisms of habituation in detail and how to detect them.

Stop guessing. Start measuring.

PauseCafé records the real caffeine content of every drink, so your daily total actually means something. Free, no adverts.